Cresco Labs is trading 5.42% up now at $0.78, with the move appearing more consistent with broader risk appetite and strength across parts of the cannabis group than with a company-specific catalyst.
- No new company-specific announcement dated September 22, 2026, was identified; the latest notable news was former CBOE chief Edward Tilly’s appointment to the board, effective September 18.
- IM Cannabis was reported up 30.96% on September 22, while Nasdaq was up 0.56%, providing supportive market context.